Results 181 to 190 of about 31,482 (296)
Comparative genomic analysis of poly-γ-glutamic acid producing Bacillus licheniformis strains isolated from dairy products. [PDF]
Okuofu SI +5 more
europepmc +1 more source
Evaluation of Discontinuation and Re‐Initiation of Biologic Therapies in Psoriasis: Real‐World Data
The cumulative probability of remaining relapse‐free following biologic therapy discontinuation was 35.6%, 19%, 11.6%, and 9.1% at 6, 12, 18, and 24 months, respectively. Prolonged relapse durations were associated with a low baseline PASI score, the presence of a PASI 90 response at discontinuation, the absence of triggering factors, and the use of IL‐
Ahmet Taha Aydemir, Nihal Kundakcı
wiley +1 more source
Crystal structure of PM1Pgh, a poly-γ-glutamate hydrolase from Bacillus phage PM1. [PDF]
Abe K, Fukui K, Ogura Y.
europepmc +1 more source
Aire and Fezf2 Shape the Medullary Thymic Epithelial Cell Immunopeptidome for Central Tolerance
Central tolerance is shaped not merely by promiscuous gene expression in medullary thymic epithelial cells (mTECs), but by the subset of self‐peptides ultimately presented on MHC class II molecules. We propose a multilayered framework in which AIRE/Aire and FEZF2/Fezf2, together with specialised differentiation programmes—including thymic mimetic‐cell ...
Geraldo Aleixo Passos +5 more
wiley +1 more source
Aqueous Carbon Capture Using Guanidinium-Functionalized Hollow Fiber Sorbent Contactors. [PDF]
Danielson MK +14 more
europepmc +1 more source
ABSTRACT Aim To evaluate the clinical, radiographic, histological and patient‐reported outcome measures (PROMs) of soft‐tissue augmentation (STA) during implant placement in the aesthetic zone using a connective tissue graft (CTG) or a volume‐stable collagen matrix (VCMX). Materials and Methods In this three‐arm randomised controlled trial, 25 patients
Louiza Papantonatou +4 more
wiley +1 more source
Litifilimab efficacy on skin outcomes in cutaneous lupus erythematosus in the Phase 2 LILAC study
Our findings show that greater proportions of litifilimab‐treated participants than placebo experienced 20%, 50%, 70% or 90% improvements in CLASI‐A score from baseline and CLASI‐A scores of 0–1 or 0–3. Similar results were observed using physician global assessments, supporting the Phase 2 LILAC study primary analysis in CLE.
Victoria P. Werth +8 more
wiley +1 more source
Staple line coverage with suture fixation of polyglycolic acid patch for primary spontaneous pneumothorax. [PDF]
Kim YS, Ryu S.
europepmc +1 more source

